Christine Castellano
Chief Corporate Affairs and Brand Strategy Officer
Replay available
Allogene Therapeutics, Inc. (ALLO) Q4 2025 Earnings Call
Allogene Therapeutics, Inc. (NASDAQ: ALLO) Q4 2025 earnings conference call, held 2026-03-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. David Chang
President and Chief Executive Officer
Dr. Zachary Roberts
Executive Vice President of Research and Development and Chief Medical Officer
Jeff Parker
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Allogene Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.197 Thank you for standing by. Welcome to Allogene Therapeutics' fourth quarter 2025 conference 00:00:04.197 -- 00:00:07.942 call. After the speaker's presentation, there'll be a question and answer session. 00:00:07.942 -- 00:00:11.307 To ask a question during the session, you'll need to press star 1-1 on your telephone. 00:00:11.307 -- 00:00:14.191 You will then hear an automated message advising your hand is raised. 00:00:14.191 -- 00:00:17.275 To withdraw your question, please press star 1-1 again. 00:00:17.275 -- 00:00:19.899 Please be aware that today's conference call is being recorded. 00:00:19.899 -- 00:00:24.065 I would like to turn the call over to Christine Castellano, Chief Corporate Affairs and 00:00:24.065 -- 00:00:28.128 Brand Strategy Officer. Ms. Castellano, please go ahead. 00:00:29.427 -- 00:00:33.151 Thank you, Operator, and welcome everyone to AllerGene's conference call. 00:00:33.151 -- 00:00:37.175 After the market closed, AllerGene issued a press release that provided a business update 00:00:37.175 -- 00:00:40.959 and financial results for the fourth quarter and year-end 2025. 00:00:40.959 -- 00:00:44.663 This press release and today's webcast are available on our website. 00:00:44.663 -- 00:00:48.507 Following our prepared remarks, we will host a Q&A session and will aim to keep the call 00:00:48.507 -- 00:00:53.052 to under an hour. I'm joined today by Dr. David Chang, President and Chief Executive 00:00:53.052 -- 00:00:57.717 Officer, Dr. Zachary Roberts, Executive Vice President of Research and Development and 00:00:57.717 -- 00:01:01.747 Chief Medical Officer, and Jeff Parker, Chief Financial Officer. 00:01:01.747 -- 00:01:05.111 During today's call, we will be making certain forward-looking statements. 00...